Plain-English translation of NCT04295252 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study that collects detailed medical information from patients admitted to intensive heart care units with cardiogenic shock—a life-threatening condition where the heart can't pump enough blood to the body. Researchers are studying all patients with this condition, regardless of what caused it, to better understand the different types of cardiogenic shock, how hospitals are treating them, and what happens to patients over time.
Cardiogenic shock is a medical emergency with very high short-term death rates. Most previous research focused only on shock caused by heart attacks, but recent studies show that many patients develop cardiogenic shock from other causes—and these patients do just as poorly. This study exists to get a complete picture of all cardiogenic shock patients so hospitals can develop better specialized care systems and doctors can make faster, more effective treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you qualify, your doctors will record detailed information about your condition, what caused your cardiogenic shock, what medications and devices you receive, and your health outcomes during and after your hospital stay. You are not receiving a new medication or undergoing additional procedures beyond your normal medical care—instead, researchers are collecting information from your medical records to better understand cardiogenic shock patterns and treatment results.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Italy
Enrollment target
~3,000 participants
Started
July 2020
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alice Sacco, MD
Niguarda Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.